Burrill & Co.

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.
By a GenomeWeb staff reporter

Under the agreement, the two companies will co-invest into life science opportunities in China.

The building, estimated to cost $6 million, would include space configurable for either laboratory or light industrial use, designed for life-sci users that do not need the intensive use of utilities available in more traditional lab buildings.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.